Skip to content
healthcare.dev
Get a free key

Risedronate Sodium

NDC 0093-3100, Risedronate Sodium, tablet, film coated, from Teva Pharmaceuticals USA, Inc..

Product NDC
0093-3100
Status
Listed
Labeler
Teva Pharmaceuticals USA, Inc.
Dosage form
TABLET, FILM COATED
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA077132
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0093-3100 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • RISEDRONATE SODIUM MONOHYDRATE30 mg/1

Pharmacologic classes

Bisphosphonate [EPC]; Diphosphonates [CS]

Package NDCNDC-11Package
0093-3100-560009331005630 TABLET, FILM COATED in 1 BOTTLE (0093-3100-56)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/dddcd321-4d2e-4643-bf3c-7b752b33ba39

Use it

Look up 0093-3100 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0093-3100 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0093-3100. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.